DK0792354T3 - Målrettede T-lymfocytter - Google Patents

Målrettede T-lymfocytter

Info

Publication number
DK0792354T3
DK0792354T3 DK95937931T DK95937931T DK0792354T3 DK 0792354 T3 DK0792354 T3 DK 0792354T3 DK 95937931 T DK95937931 T DK 95937931T DK 95937931 T DK95937931 T DK 95937931T DK 0792354 T3 DK0792354 T3 DK 0792354T3
Authority
DK
Denmark
Prior art keywords
lymphocytes
tcr
target cells
targeted
heterologous
Prior art date
Application number
DK95937931T
Other languages
English (en)
Inventor
Bradley Michael John Stringer
Original Assignee
Cellfactors Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellfactors Plc filed Critical Cellfactors Plc
Application granted granted Critical
Publication of DK0792354T3 publication Critical patent/DK0792354T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464454—Enzymes
    • A61K39/464464—GTPases, e.g. Ras or Rho
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464484—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/464486—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
DK95937931T 1994-11-16 1995-11-16 Målrettede T-lymfocytter DK0792354T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9423085A GB9423085D0 (en) 1994-11-16 1994-11-16 Targeted T lymphocytes
PCT/GB1995/002691 WO1996015238A1 (en) 1994-11-16 1995-11-16 Targeted t lymphocytes

Publications (1)

Publication Number Publication Date
DK0792354T3 true DK0792354T3 (da) 2003-05-19

Family

ID=10764464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937931T DK0792354T3 (da) 1994-11-16 1995-11-16 Målrettede T-lymfocytter

Country Status (16)

Country Link
EP (1) EP0792354B1 (da)
JP (1) JPH10511542A (da)
KR (1) KR970707280A (da)
AT (1) ATE231550T1 (da)
AU (1) AU687271B2 (da)
CA (1) CA2203934A1 (da)
CZ (1) CZ289455B6 (da)
DE (1) DE69529473T2 (da)
DK (1) DK0792354T3 (da)
ES (1) ES2191065T3 (da)
GB (1) GB9423085D0 (da)
HU (1) HUT77472A (da)
MX (1) MX9703535A (da)
NZ (1) NZ295418A (da)
PT (1) PT792354E (da)
WO (1) WO1996015238A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717248A1 (en) 1997-06-04 2006-11-02 Oxford Biomedica (UK) Limited Tumor targeted vector
US7276488B2 (en) 1997-06-04 2007-10-02 Oxford Biomedica (Uk) Limited Vector system
EP1242456B1 (en) 1999-11-18 2008-10-15 Oxford Biomedica (UK) Limited Scfv antibodies against disease associated molecules
WO2003068819A1 (en) 2001-12-22 2003-08-21 4-Antibody Ag Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
KR101130597B1 (ko) 2005-09-13 2012-04-02 다카라 바이오 가부시키가이샤 Ｔ 세포 리셉터 및 그 리셉터를 코드하는 핵산
JP5292550B2 (ja) * 2007-03-23 2013-09-18 静岡県 Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US9181527B2 (en) 2009-10-29 2015-11-10 The Trustees Of Dartmouth College T cell receptor-deficient T cell compositions
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
CN110511278A (zh) 2012-05-07 2019-11-29 达特茅斯大学理事会 抗b7-h6抗体、融合蛋白及其使用方法
US11203783B2 (en) 2013-11-21 2021-12-21 Repertoire Genesis Incorporation T cell receptor and B cell receptor repertoire analysis system, and use of same in treatment and diagnosis
CN110627895B (zh) * 2018-06-25 2021-03-23 北京大学 肺癌特异性tcr及其分析技术和应用
WO2023039242A2 (en) * 2021-09-13 2023-03-16 Achelois Biopharma, Inc. Multivalent interferon particles compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
NZ234586A (en) * 1989-07-19 1993-02-25 Arthur Allen Vandenbark Peptide of a t-cell receptor capable of inducing protection from immune-related disease
EP0722738A3 (en) * 1991-01-22 1996-10-23 Immune Response Corp Inc Vaccination and methods against diseases originating from pathogenic responses by specific populations of T cells

Also Published As

Publication number Publication date
JPH10511542A (ja) 1998-11-10
NZ295418A (en) 2000-02-28
AU3875495A (en) 1996-06-06
MX9703535A (es) 1997-08-30
EP0792354B1 (en) 2003-01-22
PT792354E (pt) 2003-06-30
DE69529473T2 (de) 2004-01-08
CZ144297A3 (en) 1997-10-15
CZ289455B6 (cs) 2002-01-16
AU687271B2 (en) 1998-02-19
DE69529473D1 (de) 2003-02-27
EP0792354A1 (en) 1997-09-03
WO1996015238A1 (en) 1996-05-23
CA2203934A1 (en) 1996-05-23
ATE231550T1 (de) 2003-02-15
KR970707280A (ko) 1997-12-01
HUT77472A (hu) 1998-05-28
ES2191065T3 (es) 2003-09-01
GB9423085D0 (en) 1995-01-04

Similar Documents

Publication Publication Date Title
DE69529473D1 (de) Gezielte t-lymfozyten
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
BR9305482A (pt) Processo de evocar em um hospedeiro mamífero uma resposta imune protetora contra infecção por helicobacter, composição de vacina adequada para o tratamento de infecção por helicobacter, vacina, processo de proporcionar proteção passiva a um hospedeiro mamífero contra infecção por helicobacter, anticanticorpo monoclonal e linhagem celular
ZA97721B (en) Methods for retreatment of patients afflicted with hepatitis C using consensus interferon.
ATE349198T1 (de) Zusammensetzung und verfahren zur krebs-antigen- immuntherapie
SE9602819L (sv) Anordning för värmebehandling
DK184583A (da) Beskyttelseshjelm med fastholdelseskrave
ATE54827T1 (de) Material und verfahren fuer herpes simplex virusimpfung.
ATE321859T1 (de) B2microglobulin fusionsproteine und varianten mit hoher affinität
DK419283D0 (da) Alkoholsubstituerede amider, fremgangsmade til fremstilling heraf samt anvendelse ved fremstilling af stoebebare polyurethanelastomerer
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
IT1281203B1 (it) Dispositivo per l'esecuzione di tagli in direzione di avanzamento di pezzi di materiale sottile.
GB2264949B (en) Measles virus recombinant poxvirus vaccine
NO163039C (no) Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer.
NO920331D0 (no) Biologisk preparat samt bruk derav
IT1242125B (it) Apparecchio di riscaldamento e riscaldatore per esso.
ATA112988A (de) Schutzvorrichtung fuer den einlaufspalt
DE69130845D1 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
DE68902481D1 (de) Vorrichtung fuer verstellbare stuehle.
IT8068619A0 (it) Procedimento e dispositivo per trattamento di articoli con materiale particellare particolarmente per la tenacizzazione di articoli di vetro
DE3850261D1 (de) Gen des hüllproteins des gurkenmosaikvirus.
ES2129353A1 (es) Sistema de montaje de placas de coccion.
FR2648712B1 (fr) Vaccin contre le virus de la leucemie bovine
LTIP1883A (en) The calf embryo lung cell culture for cutivation of bovine leukemia virus
ATE79297T1 (de) Heizvorrichtung fuer kohlepartikeln.